-
Product Insights
Stearoyl CoA Desaturase – Drugs In Development, 2023
Global Markets Direct’s Stearoyl CoA Desaturase provides in depth analysis on Stearoyl CoA Desaturase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Stearoyl CoA Desaturase targeted therapeutics...
-
Product Insights
Acetyl CoA Carboxylase – Drugs In Development, 2023
Global Markets Direct’s Acetyl CoA Carboxylase provides in depth analysis on Acetyl CoA Carboxylase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Acetyl CoA Carboxylase targeted therapeutics...
-
Product Insights
Acetyl CoA Carboxylase 2 – Drugs In Development, 2023
Global Markets Direct’s Acetyl CoA Carboxylase 2 provides in depth analysis on Acetyl CoA Carboxylase 2 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Acetyl CoA Carboxylase...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TLC-3595 in Insulin Resistance
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TLC-3595 in Insulin Resistance report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TLC-3595 in Insulin Resistance Drug Details: TLC-3595 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Atorvastatin + Ezetimibe) in Hypercholesterolemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Atorvastatin + Ezetimibe) in Hypercholesterolemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Atorvastatin + Ezetimibe) in Hypercholesterolemia Drug Details: Atorvastation in combination with...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – GDD-3898 in Acne Vulgaris
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GDD-3898 in Acne Vulgaris report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GDD-3898 in Acne Vulgaris Drug Details: GDD-3898 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (Atorvastatin + Ezetimibe) in Hyperlipidemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Atorvastatin + Ezetimibe) in Hyperlipidemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Atorvastatin + Ezetimibe) in Hyperlipidemia Drug Details: Atorvastation in combination with...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Rosuvastatin ER in Dyslipidemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rosuvastatin ER in Dyslipidemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rosuvastatin ER in Dyslipidemia Drug Details: Rosuvastatin extended-release capsule (LYN-047) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GDD-3898 in Dermatological Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GDD-3898 in Dermatological Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GDD-3898 in Dermatological Disorders Drug Details: GDD-3898 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GDD-3898 in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GDD-3898 in Obesity report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GDD-3898 in Obesity Drug Details: GDD-3898 is under development for the treatment of...